BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35275279)

  • 1. Epidemiologic disparities in colon cancer screening and adherence during the COVID-19 pandemic: a retrospective cohort analysis.
    Nwankwo EC; Hendrix C; Pollard K; Kallal C; Cruschiel T; Buckhold F; Hachem C
    Int J Colorectal Dis; 2022 Apr; 37(4):849-854. PubMed ID: 35275279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonoscopy screening and surveillance disparities during the COVID-19 pandemic.
    Randle HJ; Gorin A; Manem N; Feustel PJ; Antonikowski A; Tadros M
    Cancer Epidemiol; 2022 Oct; 80():102212. PubMed ID: 35816937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with colorectal cancer screening adherence and the impact of COVID-19 on screening patterns in Connecticut, USA.
    Gangcuangco LMA; Rivas T; Basnet A; Ryu DY; Qaiser M; Usman R; Costales VC
    Intern Emerg Med; 2022 Nov; 17(8):2229-2235. PubMed ID: 35922730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
    Mazidimoradi A; Tiznobaik A; Salehiniya H
    J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in uptake of stool-based colorectal cancer screening during the Covid-19 pandemic.
    Miller EA; Pinsky PF
    Cancer Causes Control; 2023 Oct; 34(10):887-895. PubMed ID: 37310565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of delaying colonoscopies during the COVID-19 pandemic on colorectal cancer detection and prevention.
    Holland J; Cwintal M; Rigas G; Pang AJ; Vasilevsky CA; Morin N; Ghitulescu G; Faria J; Boutros M
    Surg Endosc; 2022 Dec; 36(12):9364-9373. PubMed ID: 35428894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
    de Jonge L; van de Schootbrugge-Vandermeer HJ; Breekveldt ECH; Spaander MCW; van Vuuren HJ; van Kemenade FJ; Dekker E; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
    PLoS One; 2022; 17(6):e0270223. PubMed ID: 35749423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Decisions Regarding Rescheduling Colonoscopies Postponed Due to the COVID-19 Pandemic.
    Linz MO; Lorincz-Comi N; Kuwatch AA; Cooper GS
    Dig Dis Sci; 2023 Dec; 68(12):4339-4349. PubMed ID: 37794293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
    Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
    BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
    van Wifferen F; de Jonge L; Worthington J; Greuter MJE; Lew JB; Nadeau C; van den Puttelaar R; Feletto E; Yong JHE; Lansdorp-Vogelaar I; Canfell K; Coupé VMH;
    J Med Screen; 2022 Jun; 29(2):72-83. PubMed ID: 35100894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation.
    Hijos-Mallada G; Alfaro E; Navarro M; Cañamares P; Ariño I; Charro M; Bruno C; Solano M; Pardillos A; Jimeno C; Carrera-Lasfuentes P; Lanas A; Domper-Arnal MJ
    Gastroenterol Hepatol; 2023 Nov; 46(9):702-709. PubMed ID: 36716926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
    Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
    Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Colonoscopy for Colon Cancer in Women during COVID-19 Pandemic.
    Bestari MB; Joewono IR
    Acta Med Indones; 2021 Jan; 53(1):132-139. PubMed ID: 33818416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities.
    Nodora JN; Gupta S; Howard N; Motadel K; Propst T; Rodriguez J; Schultz J; Velasquez S; Castañeda SF; Rabin B; Martínez ME
    J Natl Cancer Inst; 2021 Aug; 113(8):962-968. PubMed ID: 32780851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain).
    Vives N; Binefa G; Vidal C; Milà N; Muñoz R; Guardiola V; Rial O; Garcia M
    Prev Med; 2022 Feb; 155():106929. PubMed ID: 34954239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality.
    Ricciardiello L; Ferrari C; Cameletti M; Gaianill F; Buttitta F; Bazzoli F; Luigi de'Angelis G; Malesci A; Laghi L
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1410-1417.e9. PubMed ID: 32898707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis.
    Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.